Skip to main content
OpenTrials

Clinical trial condition

Amyotrophic Lateral Sclerosis

Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.

707 public trials 173 recruiting studies
Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis trial results

Active, Not Recruiting

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

NCT06643481

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Loma Linda University Health Loma Linda, California, United States
  • Keck Medical Center USC Los Angeles, California, United States
  • UC San Francisco Medical Center San Francisco, California, United States
View all 74 locations
View Trial Details
Active, Not Recruiting

TRIAL READY (Clinical Trial Readiness)

NCT03912987

Conditions
ALS-Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, Brain Diseases, +18 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Kansas Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Phenotype, Genotype and Biomarkers 2

NCT04875416

Conditions
Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +27 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Cape Town Cape Town, South Africa
View Trial Details
Active, Not Recruiting

Phenotype, Genotype & Biomarkers in ALS and Related Disorders

NCT02327845

Conditions
Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +28 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California San Diego (UCSD) San Diego, California, United States
  • California Pacific Medical Center (CPMC) San Francisco, California, United States
  • University of Miami Miami, Florida, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

NCT05633459

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Universitaire Ziekenhuizen Leuven (UZ Leuven) Leuven, Belgium
  • University of Calgary Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • Sunnybrook Health Science Centre Toronto, Ontario, Canada
View all 15 locations
View Trial Details
Active, Not Recruiting

Novel MRI Biomarkers for Monitoring Disease Progression in ALS

NCT03362658

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Utah Salt Lake City, Utah, United States
  • University of Calgary / Heritage Medical Research Clinic Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS

NCT05279755

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Worldwide Clinical Trials Early Phase Services San Antonio, Texas, United States
  • The Neuro - Montréal Neurological Institute-Hospital Montreal, Quebec, Canada
  • University Medical Center Utrecht Utrecht, Netherlands
View Trial Details
Active, Not Recruiting

A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT06441682

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • UZ Leuven Leuven, Belgium
  • Kaye Edmonton Clinic Edmonton, Canada
  • Montreal Neurological Institute and Hospital Montreal, Canada
  • Aarhus Universitets Hospital Aarhus, Denmark
View Trial Details

Related conditions